Cargando…

The impacts of vaccination status and host factors during early infection on SARS-CoV-2 persistence: a retrospective single-center cohort study()

BACKGROUND: Viral persistence is a crucial factor that influences the transmissibility of SARS-CoV-2. However, the impacts of vaccination and physiological variables on viral persistence have not been adequately clarified. METHODS: We collected the clinical records of 377 COVID-19 patients, which co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiangxiang, Zhang, Yifan, Wang, Wanhai, Fang, Fang, Zhang, Wenhong, Zhu, Zhaoqin, Wan, Yanmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708622/ https://www.ncbi.nlm.nih.gov/pubmed/36476489 http://dx.doi.org/10.1016/j.intimp.2022.109534

Ejemplares similares

Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein
por: Tian, Xiangxiang, et al.
Publicado: (2022)

Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity
por: Jia, Liqiu, et al.
Publicado: (2022)

Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
por: Feng, Yanmeng, et al.
Publicado: (2021)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population
por: Feng, Yanmeng, et al.
Publicado: (2023)

Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations
por: Zhang, Yi, et al.
Publicado: (2022)

SARS-CoV-2 intra-host single-nucleotide variants associated with disease severity
por: Zhang, Yi, et al.
Publicado: (2022)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Proteomic characterization of Omicron SARS-CoV-2 host response
por: Bao, Jianfeng, et al.
Publicado: (2022)

Immune Correlates of Disseminated BCG Infection in IL12RB1-Deficient Mice
por: Wang, Xuyang, et al.
Publicado: (2022)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients
por: Fang, Zhixiong, et al.
Publicado: (2020)

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
por: Li, Jingjiao, et al.
Publicado: (2021)

SARS-CoV-2 variants, immune escape, and countermeasures
por: Zhang, Yi, et al.
Publicado: (2022)

Prevention of host-to-host transmission by SARS-CoV-2 vaccines
por: Mostaghimi, Darius, et al.
Publicado: (2022)

Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Clinical SARS-CoV-2 Kinetic Profiles Are Dependent on the Viral Strain and Host Vaccination Status
por: Gunawardana, Manjula, et al.
Publicado: (2022)

SARS-CoV2 infectivity is potentially modulated by host redox status
por: Singh, Jaswinder, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

SARS-CoV-2 helicase NSP13 hijacks the host protein EWSR1 to promote viral replication by enhancing RNA unwinding activity
por: Zeng, Hongxiang, et al.
Publicado: (2022)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis
por: Liu, Yili, et al.
Publicado: (2021)

Redox Status Is the Mainstay of SARS-CoV-2 and Host for Producing Therapeutic Opportunities
por: Thirupathi, Anand, et al.
Publicado: (2022)

Persistent but atypical germinal center reaction among 3(rd) SARS-CoV-2 vaccination after rituximab exposure
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2
por: Pérez-Lago, Laura, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Tian, Xiaodong, et al.
Publicado: (2021)

SARS-CoV2 vaccination status among psychiatry inpatients: a retrospective cohort analysis
por: Andreu, H., et al.
Publicado: (2023)

An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota
por: Li, Shaoshuai, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Molecular surveillance of potential SARS-CoV-2 reservoir hosts in wildlife rehabilitation centers
por: Mena, Juan, et al.
Publicado: (2023)

The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
por: Song, Wanchen, et al.
Publicado: (2023)

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
por: Ngo, Dat, et al.
Publicado: (2023)

Variable Persister Gene Interactions with (p)ppGpp for Persister Formation in Escherichia coli
por: Liu, Shuang, et al.
Publicado: (2017)

SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020)

The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2
por: Briguglio, Matteo, et al.
Publicado: (2020)

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
por: Xu, Yi, et al.
Publicado: (2020)

SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients
por: Lei, Hui, et al.
Publicado: (2020)

SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study
por: Luchetti Gentiloni, Michele Maria, et al.
Publicado: (2022)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients
por: Yan, Xiquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68eokaf1j6mqc1dvh9cl1f6qi6